StockWatch
·
Pharmaceuticals
Clarification10 Jun 2026, 01:31 pm

Morepen Labs Denies Price-Sensitive News for Volume Surge

AI Summary

Morepen Laboratories Ltd has responded to stock exchange queries regarding a recent surge in its share volume. The company clarified that it regularly intimates all compliances as per SEBI (LODR) Regulations, 2015. Morepen Laboratories confirmed that there are no pending announcements, events, or price-sensitive information that could explain the significant increase in trading volume. The company suggested that the market activity may be driven by general market trends.

Key Highlights

  • Company denies any price-sensitive information driving share volume.
  • Regular compliances with SEBI (LODR) Regulations confirmed.
  • No pending announcements or events that could impact share price.
  • Volume surge attributed to market-driven factors.
  • Company assures ongoing adherence to disclosure norms.